Transfusion management in the trauma patient
- PMID: 36226706
- DOI: 10.1097/MCC.0000000000000992
Transfusion management in the trauma patient
Abstract
Purpose of review: Transfusion of blood products is lifesaving in the trauma ICU. Intensivists must be familiar with contemporary literature to develop the optimal transfusion strategy for each patient.
Recent findings: A balanced ratio of red-blood cells to plasma and platelets is associated with improved mortality and has therefore become the standard of care for resuscitation. There is a dose-dependent relationship between units of product transfused and infections. Liquid and freeze-dried plasma are alternatives to fresh frozen plasma that can be administered immediately and may improve coagulation parameters more rapidly, though higher quality research is needed. Trauma induced coagulopathy can occur despite a balanced transfusion, and administration of prothrombin complex concentrate and cryoprecipitate may have a role in preventing this. In addition to balanced ratios, viscoelastic guidance is being increasingly utilized to individualize component transfusion. Alternatively, whole blood can be used, which has become the standard in military practice and is gaining popularity at civilian centers.
Summary: Hemorrhagic shock is the leading cause of death in trauma. Improved resuscitation strategy has been one of the most important contemporary advancements in trauma care and continues to be a key area of clinical research.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
References
-
- Lewis M, Shulman I, Hudgins J, et al. Essentials of emergency transfusion—the complement to stop the bleed. J Trauma Acute Care Surg 2019; 87:420–429.
-
- Black JA, Pierce VS, Juneja K, Holcomb JB. Complications of hemorrhagic shock and massive transfusion-a comparison before and after the damage control resuscitation era. Shock 2021; 56:42–51.
-
- Holcomb JB, del Junco DJ, Fox EE, et al. The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg 2013; 148:127–136.
-
- Baraniuk S, Tilley BC, del Junco DJ, et al. Pragmatic Randomized Optimal Platelet and Plasma Ratios (PROPPR) Trial: design, rationale and implementation. Injury 2014; 45:1287–1295.
-
- Holcomb JB, Tilley BC, Baraniuk S, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA 2015; 313:471–482.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
